Nasus Pharma Ltd.

NSRX | AMEX

Price Alert Chart Builder DCF Calculator

$3.16

-$0.15 (-4.53%)

At close: Oct 30, 2026, 3:59 PM ET

$3.16

$0.00 (0.00%)

After-hours: Oct 30, 2026, 3:59 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024 Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023 Dec 31, 2023	Q3 2023 Sep 30, 2023	Q2 2023 Jun 30, 2023	Q1 2023 Mar 31, 2023
PE Ratio	-3.65	-4.44	-29.52	n/a	-31.73	-34.38	-37.50	-35.87	-33	-41.25	-55	-95.49	-307.84	-615.67
PEG Ratio	-0.04	-0.06	n/a	n/a	n/a	-0.46	n/a	1.30	n/a	-5.34	n/a	-0.28	n/a	n/a
PS Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
PB Ratio	3.52	2.22	29.80	n/a	n/a	n/a	-18.24	n/a	-11.85	n/a	n/a	n/a	n/a	n/a
P/FCF Ratio	-11.52	-16.35	-55.31	n/a	-525.79	-80.47K	-88.1K	-83.87K	-75.51K	-62.78K	-56.31K	-76.96K	-41.27K	-82.53K
P/OCF Ratio	-11.54	-16.39	-55.47	n/a	-525.78	-80.47K	-88.1K	-83.87K	-75.51K	-62.78K	-56.31K	-76.96K	-41.27K	-82.53K
OCF/S Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt / Equity Ratio	0.01	0.01	0.04	0.04	n/a	n/a	-0.56	n/a	-0.82	n/a	n/a	n/a	n/a	n/a
Quick Ratio	8.77	8.77	2.24	2.24	n/a	n/a	0.12	n/a	0.16	n/a	n/a	n/a	n/a	n/a
Current Ratio	8.77	8.77	2.24	2.24	n/a	n/a	0.12	n/a	0.16	n/a	n/a	n/a	n/a	n/a
Asset Turnover	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Interest Coverage	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Return on Equity	-54.04%	-27.02%	-50.29%	n/a	n/a	n/a	10.29%	n/a	9.34%	n/a	n/a	n/a	n/a	n/a
Return on Assets	-47.73%	-23.87%	-27.82%	n/a	n/a	n/a	-46.09%	n/a	-42.70%	n/a	n/a	n/a	n/a	n/a
Return on Invested Capital	-54.43%	-27.21%	-42.82%	n/a	n/a	n/a	21.10%	n/a	28.11%	n/a	n/a	n/a	n/a	n/a
Dividend Yield	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
FCF Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Net Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
EBITDA Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a